Molecular pharmacological approach to the disturbances of brain neuron circuits involved in schizophrenia
Molecular pharmacological approach to the disturbances of brain neuron circuits involved in schizophrenia
批准号:
06670993
负责人:
NISHIKAWA Toru
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A psychotomimetic drug methamphetamine (MAP) produces a neuroleptic-responsive schizophreniform psychosis in humans while phencyclidine (PCP) psychosis includes neuroleptic-resistant symptoms which are indistinguishable from those of schizophrenis. Acute administration of MAP (4.8 mg/kg, subcutaneously (s.c.)) caused a widespread induction of nuclear c-Fos-like immunoreactivity in rat brain at 56-80 postnatal days in a dopamine antagonist-sensitive manner. The greatest density of c-Fos positive cells was found in the pyriform cortex and olfactory tubercle followed by the entorhinal cortex, II-VI layrs of the neocortex, striatum, amygdala, nucleus accumbens, septal unclei, granular cell layr of the cerebellum, thalamus, hypothalamus, substantia nigra, etc. In 8-day-old neonatal rats, acute injection of these drugs failed to cause c-fos expression from the laver II htrough V of the neocortex, but induced the proto-oncogene product in a deeper aprt of the layr VI of the neocortex, the pal … More eocortex (including the pyriform and entorhinal cortex) and the above subcortical areas. MAP-induced c-Fos positive cells in the neocortex increased in number and distribution with postnatal development and showed the adult pattern after 21-23 postnatal days. The distribution patterns of c-Fos-positive cells after PCP treatment were different from those after MAP.Thus, a single injection of PCP (5-10mg/kg, s.c.) produced the dense expression of c-Fos-like immunoreactivity in the deeper layrs (IV-VI) of the neocortex and pyriform cortex, but the very sparse expression in the striatum, olfactory tubercle and superficial layrs (I-III) of the necortex in the young adult periods in a dopamine antagonist-resistant fashion. These expression patterns were similar to those of a selective NMDA receptor antagonist dizocilpine. In the neonatal periods, PCP induced very low levels of c-Fos-like immunoreactivity in the neocortex while the pyriform cortex was dense with c-Fos positive cells. PCP-induced c-Fos-immunostaining in th brain showed the adult pattern after 21-25 postnatal days. The above developmental changes in the patterns of c-fos expression in the neocortical areas might reflect differences in responsive neuronal circuits to the drugs between the neonatal and young adult periods. Because acute or long-term behavioral effects of these drugs alter around the third week of postnatal life, these results suggest that the maturation of certain neuronal circuits in the neocortex might be crucial for the acquisition of the adult patterns of behavioral responses or motor functions. We have nowtried to identify molecules contributing to such developmental changes in the discrete brain regions because these molecules should play a pivotal role in expression and regulation of psychomotor functions that may be disturbed in schizopherenic patients. To this end, we have employed a RNA arbitarily primed PCR technique for the detection of cDNAs that represent developmentally regulate Less
期刊论文(98)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kashiwa A, Nishikawa T, Nishijima K, Umino A and Takahashi K.: "Dizocilpine(MK-801)elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex." Neurochem. Int.26. 85-90 (1995)
Kashiwa A、Nishikawa T、Nishijima K、Umino A 和 Takahashi K.:“地佐环平 (MK-801) 会引起大鼠内侧额叶皮层细胞外多巴胺释放对河豚毒素敏感的增加。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanii Y,Nishikawa T,Hashimoto A and Takahashi K: "Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactiviy, stereotypy and ataxia in the rat." J.Pharmacol.EXP.Ther.269. 1040-1048 (1994)
Tanii Y、Nishikawa T、Hashimoto A 和 Takahashi K:“丙氨酸和丝氨酸对映体对苯环己哌啶诱导的大鼠多动症、刻板性和共济失调的立体选择性拮抗作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishikawa T and Scatton B:"GABAergic inhibition of ascending serotonergic neurons in rat brain. In Serotonin in the Central Nervous System and Periphery(eds. A. Takada and G. Curzon)," Elsevier, Amsterdam,6 (1995)
Nishikawa T 和 Scatton B:“GABA 能抑制大鼠大脑中的上行血清素能神经元。中枢神经系统和外周的血清素(A. Takada 和 G. Curzon 编辑)”,Elsevier,阿姆斯特丹,6 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hashimoto,A.et al.: "Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis" Neurosuience. (印刷中).
Hashimoto, A. 等人:“通过体内微透析揭示的大鼠脑中内源性游离 D-丝氨酸的细胞外浓度”Neurosuience(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
岩間久行・西川徹: "精神分裂病II-おもに病因・病態論の立場から-(シリーズ精神科症例集2)" 佐藤光源編集,中山書店,東京, 396 (1994)
岩间久之和西川彻:《精神分裂症 II - 主要从病因学和病理生理学的角度 - (系列精神病病例集 2)》由佐藤光编辑,中山书店,东京,396 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 44 条
Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
-
批准号:21390330
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:NISHIKAWA Toru
-
依托单位:
Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
-
批准号:19390302
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:NISHIKAWA Toru
-
依托单位:
Elucidation of molecular pathomechanisms of schizophrenia
-
批准号:17025016
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$68.22万
-
财政年份:2005
-
负责人:NISHIKAWA Toru
-
依托单位:
A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
-
批准号:14207040
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.2万
-
财政年份:2002
-
负责人:NISHIKAWA Toru
-
依托单位:
A pharmacological approach to the molecular basis of disturbed brain information processing of schizophrenia
-
批准号:12470192
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.5万
-
财政年份:2000
-
负责人:NISHIKAWA Toru
-
依托单位:
精神分裂病における神経情報処理障害の原因となる遺伝子異常の探索
-
批准号:10670929
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:NISHIKAWA Toru
-
依托单位:
Molecular mechanisms of schizophrenic symptoms
-
批准号:08671124
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:NISHIKAWA Toru
-
依托单位:
Metabolism and Physiological functions of endogenous D-serine
-
批准号:07557242
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$3.01万
-
财政年份:1995
-
负责人:NISHIKAWA Toru
-
依托单位:
Schizophrenic sympyoms-related disturbance of cerebral neurotransmission
-
批准号:04670718
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:NISHIKAWA Toru
-
依托单位:
Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat
-
批准号:02670527
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1990
-
负责人:NISHIKAWA Toru
-
依托单位:
海外基金